Justera Announces Director and Interim CEO Appointments

Rhea-AI Summary

Justera Health (OTC:SCRSF) appointed Andrew Ryu as Interim CEO and Chairman and added Ian (Ingoo) Kim to the board, effective March 12, 2026. The company says it will work toward resuming trading of its common shares on the CSE and will provide updates on progress.

The appointments are presented as steps to restore momentum, strengthen governance, and pursue opportunities in the Canadian health and wellness sector.

Positive

• Interim CEO and chairman appointed on March 12, 2026
• Two new directors added to the board effective March 12, 2026
• Company actively pursuing resumption of CSE trading for common shares

Negative

• Common shares currently not trading on CSE, requiring resumption efforts
• Leadership change is interim, indicating transitional governance period

TORONTO, ON / ACCESS Newswire / March 12, 2026 / Justera Health Ltd. (CSE:VTAL)(OTC PINK:SCRSF) ("Justera" or the "Company") is pleased to announce the appointment of Ian (Ingoo) Kim and Andrew Ryu to its Board of Directors, effective March 12, 2026.

Mr. Ryu will also assume the role of Interim Chief Executive Officer and Chairman of the board while the Company advances its operational and corporate initiatives.

The Company believes the addition of Mr. Kim and Mr. Ryu brings valuable leadership, governance, and strategic experience that will support Justera's efforts to strengthen its corporate foundation and pursue opportunities in the Canadian health and wellness sector.

"As a shareholder of Justera, I am committed to working with the Board and management to restore momentum and create long-term value", said Andrew Ryu, Interim CEO and Chairman. "My immediate priority will be to focus on having the Company's shares trading again as soon as possible while positioning Justera to move forward with a clear strategy".

The Company will be actively working toward the resumption of trading on CSE of its common shares and will provide updates as progress is made.

Andrew Ryu is a graduate of McMaster University and the University of Toronto. He was the nominee of entrepreneur of the year of Ernst Young in 2014. He was the Founder and CEO of Loyalist Group Limited (TSXV:LOY), which was recognized as a Top TSXV Company in 2013 and ranked fourth and named pick of the street in 2014. Mr. Ryu later served as CEO and Chairman of Datametrex (TSXV:DM) until May 2022, where he guided the company's strategic growth. He has also served as Director of several private and public companies, providing governance and strategic oversight.

Ian (Ingoo) Kim previously worked in the Human Resources division at LG Electronics. Throughout his career, Mr. Kim has worked with a range of technology and healthcare companies, contributing operational and organizational experience across both sectors.

About Justera Health

Established in 2020, Justera is a Canadian company focused on health and wellness. Justera's mission is to enhance Canadians overall well-being with diverse solutions catering to individual needs.

For more information about the Company, please refer to the Company's profile on SEDAR+ at www.sedarplus.ca.

For further information:

Investor Relations & Communications

Andrew Ryu, CEO and Chairman
Tel: (416) 901-5611, ext. 201
Email: info@justerahealth.com

Forward-Looking Statements:

CAUTIONARY STATEMENT ON FORWARD-LOOKING INFORMATION

This news release includes "forward-looking information", as such term is defined in applicable securities laws. Forward-looking information includes, without limitation, the success of exploration activities, price outlooks, production expectations and other similar statements concerning anticipated future events, conditions or results that are not historical facts. These statements reflect management's current estimates, beliefs, intentions and expectations; they are not guarantees of future performance. The Company cautions that all forward looking information is inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond the Company's control. Accordingly, actual future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. All statements are made as of the date of this news release and the Company is under no obligation to update or alter any forward-looking information.

###

SOURCE: Justera Health Ltd.

View the original press release on ACCESS Newswire

FAQ

Who is the new Interim CEO of Justera (SCRSF) and when was he appointed?

Andrew Ryu is the Interim CEO and Chairman, appointed effective March 12, 2026. According to the company, Mr. Ryu will lead immediate efforts to restore momentum, focus on resuming CSE trading for common shares, and reposition Justera strategically.

What board changes did Justera (SCRSF) announce on March 12, 2026?

Justera added two directors: Ian (Ingoo) Kim and Andrew Ryu, effective March 12, 2026. According to the company, the appointments are intended to strengthen leadership, governance, and strategic experience for pursuing opportunities in Canadian health and wellness.

Will Justera (SCRSF) resume trading on the CSE and what is the timeline?

The company is actively working toward resumption of CSE trading but gave no firm timeline. According to the company, management will provide updates as progress is made while prioritizing steps to have shares trading again as soon as possible.

What experience does Interim CEO Andrew Ryu bring to Justera (SCRSF)?

Andrew Ryu has prior CEO and director roles, including leading Loyalist Group and Datametrex, and entrepreneurial recognition in 2014. According to the company, his background includes governance and strategic oversight in public and private companies.

What is Ian (Ingoo) Kim's background as announced by Justera (SCRSF)?

Ian (Ingoo) Kim previously worked in HR at LG Electronics and with technology and healthcare companies. According to the company, Mr. Kim brings operational and organizational experience across tech and healthcare sectors to the board.